New crown epidemic brings new enlightenment

- Jun 12, 2020-

In 2020, the instrument information network launched the "Yi Jia said" column, which is the first high-end interview live column in the scientific instrument industry. "Yi Jia Shuo" focuses on news events or hot topics in the scientific instrument, analysis and detection industry. Each issue invites 2-3 industry leaders to carry out in-depth discussions and exchanges in the live broadcast. , Sharp point of view, to help the majority of practitioners to track the forefront of the market, analyze industry hot spots.

The current global epidemic is still spreading rapidly. In the past period, hundreds of thousands of new cases of coronary heart disease have been added globally. Many countries appear unprepared for the epidemic response. In terms of anti-epidemic experience, China is undoubtedly the most powerful speaker. So, at the beginning of the outbreak, what are the serious challenges facing the front line of anti-epidemic? To what extent are instruments and reagents scarce? In order to combat the epidemic, what effective work has the enterprise carried out? Let's take a look at how the three guests analyzed our current situation from all angles.

In order to confirm the gene sequence of pathogens, in the early stage of the outbreak, BGI was involved in the genetic testing of pathogens. During the period, a very important problem was involved, that is, how to increase the amount of detection. The rapid establishment of Huada Zhizao's "Fire Eye" laboratory provided Wuhan with a high-throughput sequencing overall solution and equipment for the construction of nucleic acid testing laboratories, with a testing throughput of 10,000 people per day ... "

"Fluorescence quantitative PCR for nucleic acid detection has long been a means of confirming the diagnosis of pathogenic microbial infectious diseases. After the outbreak, urgently cooperated to produce a large number of PCR instruments and nucleic acid extractors from the enterprise level. CDC and hospitals across the country provide nucleic acid detection testing solutions, including reagents and instruments. We quickly developed an inactivated preservation solution during the epidemic to preserve pharyngeal swab specimens ... "

Most of the economic benefits of life science instrument companies should be able to reach the expected income, but the demand for conventional conventional variety inspection instruments and reagents has stalled. After the epidemic, there may be "retaliatory" demand growth that will also increase certain economic benefits, so there must be good expectations ...

The overall economy is affected, optimistic about the long-term development of life science instruments. The detection mode promotes the development of instrument portability and even wearability in the future.


At the operational level, such as logistics, supply chain and personnel output face serious challenges; from the performance level, non-epidemic-related businesses are basically suspended, and may even be delayed for a long time. People in the society may have improved awareness of health and disease testing, and national policies are more conducive to supporting the development of more such industries ...

Technology models change business models, and two new models may be developed.


The mobile development business model and community prevention and control model of third-party laboratories have led to the birth of a new disease monitoring model, which may be the direction of future development ...

After this epidemic, there are reasons to believe that the country will make major moves in the construction of a public health system, the establishment of a high-level biosafety laboratory national system, and drug research and development. What problems and shortcomings have been exposed in China's public health system under the new crown epidemic? What market opportunities are conceived by the construction of the public health system? In the future, the country will accelerate the creation of a national system of high-level biosafety laboratories. What opportunities does this mean for the scientific instrument industry?

The organic combination of the clinical system and the disease control system and the ability of the company to quickly switch production are very important.


How to combine the clinical system and the disease control system organically is very important. In addition, as the vitality of the enterprise-the research and development of new technologies and the configuration of the innovation system are all issues that are always facing the development of the enterprise. Rapid deployment and emergency capability configuration are also ...

n the future, molecular diagnosis will start to sink into the primary hospital, and instrument manufacturers will shoulder the heavy responsibility of research and development.


The mode of accumulation and cooperation will accelerate the technological breakthrough of enterprises. Facing the needs of multiple PCR and integration, there are many key technologies that still need domestic experts to make breakthroughs ...

There will be major opportunities in platform hardware construction and scientific research capabilities.


The construction of the public health system requires the full construction of hardware, the construction of scientific research platforms, designated medical institutions, hot clinics, and community sentinels. These testing institutions all need the opportunity to strengthen and update the hardware facilities, including some communities may need some R & D opportunities can't be more than a temperature measuring gun. In addition, the cultivation of professional technical talents and universal education for all people are also essential ...